Innovation in Oncology Drug Development

Table 2

Median yearly cost in the US of 51 new oncology drugs approved between 2009 and 2014 [3].

Total oncology drugs approved by the FDA from 2009 to 2014	Primary endpoint for approval (% of total; N)	Median price per year of treatment
51	ORR (35%; 18)	$137,952
	PFS (35%; 18)	$102,677
	OS (30%; 15)	$112,370

ORR: objective response rate. PFS: progression fee survival. OS: overall survival (table adapted from [3]).